Survival time for myeloma patients nearly doubled since 2005
Over a 15-year period, the median survival time for people with myeloma has nearly doubled, increasing from 2.4 years for those diagnosed in 2005…
Over a 15-year period, the median survival time for people with myeloma has nearly doubled, increasing from 2.4 years for those diagnosed in 2005…
It started like any ordinary ache — something my mum, Esther, was all too familiar with. She often woke up with a crick in her…
The first time I saw a patient all by himself in the infusion room, I didn’t notice him. No, that’s not what happened. On that…
The U.S. Food and Drug Administration (FDA) has approved two new biosimilar drugs — versions of brand-name therapies that have no clinically meaningful differences compared…
At my last school reunion, someone asked me, “What do you do?” “I am a writer and a columnist,” I said. At the coffee…
This September, during Blood Cancer Awareness Month, major organizations are launching new campaigns to increase awareness and support for the three main types of…
Last year, while I was attending a fundraiser for breast cancer, I watched several hundred people adorned in pink shirts cheering with joy and excitement…
The first patient has been dosed in a Phase 1 clinical trial that’s testing a gene therapy for people with recurring or treatment-resistant multiple…
Dr. A is insisting that we should start treating my mother with a new myeloma medication right away. Dr. B is asking us to wait…
When you become a caregiver, nobody warns you that you’ve also become: A Google Alert in human form, always staying up to date on…